Additionally, the application of umbilical cord blood-derived stem cells in the treatment of glioma cells exerts an inhibitory effect on angiogenesis mediated by focal adhesion kinase (FAK), resulting in the upregulation of homologous phosphatase and tension in glioma cells, as well as the downregulation of Akt and PI3K signaling molecules. Here, PTK2 is linked to central nervous system cancer.